Skip to Content
Cancer Therapy Evaluation Program (CTEP)
Contact NExT
Show menu
Search this site
Last Updated: 04/30/18

William C. Timmer, PhD

William C. Timmer, PhD

Program Director

Dr. William C. Timmer joined CTEP as a Program Director in the Clinical Grants and Contracts Branch in 2007. In 2018, he became a Program Director in the Clinical Investigations Branch. He manages a portfolio of clinical grants involving brain, head and neck, lung, liver, colorectal, pancreatic, and sarcoma cancers, plus neuroblastoma, retinoblastoma and neurofibromatosis. He is the CTEP representative to the Informatics Technology for Cancer Research program, as well as the Program Director for the Adult Brain Tumor Consortium, the Childhood Cancer Survivor Study, the Neurofibromatosis NF-1 Consortium, and the Drug Resistance and Sensitivity Network.

He received his Ph.D. in Physical Chemistry from the University of Wisconsin-Milwaukee, where he intended to pursue a career in the physical sciences. However, a unique opportunity became available at NIH, and he transitioned to molecular biology and clinical sciences. He studied the immunoregulatory effects of cytokines on HIV replication in the Laboratory of Immunoregulation at the National Institute of Allergy and Infectious Diseases (NIAID), where he was mentored by Dr. Anthony Fauci.

He subsequently joined the Food and Drug Administration (FDA) where, over a 15-year period, he held a variety of positions. At the Centers for Drugs and Biologics, Dr. Timmer evaluated regulatory submissions in the areas of HIV detection kits, cellular and gene therapies, and medical devices. At the Center for Drug Evaluation and Research he participated on review teams evaluating investigational and new drug applications in the Divisions of Anesthesia, Dermatology, Neuropharmacology, Cardio-Renal, and, ultimately, Oncology Drug Products, where he was mentored by the Director of the FDA Oncology Center of Excellence, Dr. Richard Pazdur.

About the Branch Chief

Meg Mooney, MD Meg Mooney, MD, MBA, became the Acting Associate Director of CTEP in December 2018, with oversight and coordination responsibilities for the programmatic, financial, and administrative functions for the entire CTEP program, which covers a broad, multidisciplinary, clinical research effort to coordinate nationwide phase 1-3 clinical trials programs testing new treatment approaches for cancer. She is also the Chief of the Clinical Investigations Branch. More…